Each type of cause that initiates rheumatoid arthritis or RA flares differentially affects the response to therapy

Medical Hypotheses

Volumn 78, Issue 1, 2012, Pages 123-129

  Molnar Kimber, Katherine L ^a   Kimber, Charles T ^b,c  

^a Kimnar Group   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c Aquaculture Research and Education Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR4 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 21; METHOTREXATE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; OMEGA 3 FATTY ACID; SECONDARY LYMPHOID TISSUE CHEMOKINE; STAT4 PROTEIN; TUMOR NECROSIS FACTOR ANTIBODY;

ADAPTIVE IMMUNITY; ARTICLE; EPIGENETICS; GENETIC RISK; HUMAN; INFLAMMATION; JOINT INJURY; MEDICAL DECISION MAKING; MOLECULAR MIMICRY; NUTRITIONAL STATUS; RHEUMATOID ARTHRITIS; RNA SPLICING;

ADAPTIVE IMMUNITY; ARTHRITIS, RHEUMATOID; HUMANS; MODELS, BIOLOGICAL;

EID: 83155175101     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.10.006     Document Type: Article

References (98)

1. Aletaha D., Neogi T., Silman A.J., et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010, 69:1580-1588.
2. Bingham C.O., Pohl C., Woodworth T.G., et al. Developing a standardized definition for disease " flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group). J Rheumatol 2009, 36:2335-2341.
3. Elkan A.C., Hakansson N., Frostegard J., Cederholm T., Hafstrom I. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2009, 11:eR37. doi:ar2643 [pii]10.1186/ar2643.
4. Scherer H.U., Dorner T., Burmester G.R. Patient-tailored therapy in rheumatoid arthritis: an editorial review. Curr Opin Rheumatol 2010, 22:237-245.
5. Maravic M., Berge C., Daures J.P., Boissier M.C. Practices for managing a flare of long-standing rheumatoid arthritis: survey among French rheumatologists. Clin Exp Rheumatol 2005, 23:36-42.
6. Saraux A., Combe B., Blin P., et al. Survey of the therapeutic management of rheumatoid arthritis in France. the OPALE study. Clin Exp Rheumatol 2010, 28:325-332.
7. Cleland L.G., Caughey G.E., James M.J., Proudman S.M. Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. J Rheumatol 2006, 33:1973-1979.
8. Plant D., Bowes J., Potter C., et al. Genome-wide association study of genetic predictors of anti-tumour necrosis factor (TNF) treatment in rheumatoid arthritis (RA) identifies associations with polymorphisms at seven loci. Arthritis Rheum 2010, 63:645-653.
9. Assous N., Gossec L., Dieude P., et al. Rituximab therapy in rheumatoid arthritis in daily practice. J Rheumatol 2008, 35:31-34.
10. Deane K.D., Norris J.M., Holers V.M. Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation. Rheum Dis Clin North Am 2010, 36:213-241.
11. Lee H.S., Korman B.D., Le J.M., et al. Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. Arthritis Rheum 2009, 60:364-371.
12. Pedersen M., Jacobsen S., Garred P., et al. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Arthritis Rheum 2007, 56:1446-1453.
13. Mikuls T.R., Gould K.A., Bynote K.K., et al. Anti-citrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study. Arthritis Res Ther 2010, 12:R213.
14. Rieck M., Arechiga A., Onengut-Gumuscu S., et al. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007, 179:4704-4710.
15. Stahl E.A., Raychaudhuri S., Remmers E.F., et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010, 42:508-514.
16. Aho K., Koskenvuo M., Tuominen J., Kaprio J. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 1986, 13:899-902.
17. Strietholt S., Maurer B., Peters M.A., Pap T., Gay S. Epigenetic modifications in rheumatoid arthritis. Arthritis Res Ther 2008, 10:e219. doi:ar2500 [pii]10.1186/ar2500.
18. Al-Allaf A.W., Sanders P.A., Ogston S.A., Marks J.S. A case-control study examining the role of physical trauma in the onset of rheumatoid arthritis. Rheumatology (Oxford) 2001, 40:262-266.
19. Smolen J.S., Aletaha D., Steiner G. Does damage cause inflammation? Revisiting the link between joint damage and inflammation. Ann Rheum Dis 2009, 68:159-162.
20. Leirisalo-Repo M. Early arthritis and infection. Curr Opin Rheumatol 2005, 17:433-439.
21. Ebringer A., Rashid T., Wilson C. Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper. Autoimmun Rev 2010, 9:216-223.
22. Gerard H.C., Stanich J.A., Whittum-Hudson J.A., et al. Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue. Microb Pathog 2010, 48:62-68.
23. Wegner N., Lundberg K., Kinloch A., et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010, 233:34-54.
24. Luosujarvi R.A., Husman T.M., Seuri M., et al. Joint symptoms and diseases associated with moisture damage in a health center. Clin Rheumatol 2003, 22:381-385.
25. Alvarez-Lafuente R., Fernandez-Gutierrez B., de Miguel S., et al. Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis 2005, 64:1357-1359.
26. Tan L.C., Mowat A.G., Fazou C., et al. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes. Arthritis Res 2000, 2:154-164.
27. Shadidi K.R., Thompson K.M., Henriksen J.E., Natvig J.B., Aarvak T. Association of antigen specificity and migratory capacity of memory T cells in rheumatoid arthritis. Scand J Immunol 2002, 55:274-283.
28. Hughes L.B., Criswell L.A., Beasley T.M., et al. Genetic risk factors for infection in patients with early rheumatoid arthritis. Genes Immun 2004, 5:641-647.
29. Dugar M., Rankin W.A., Rowe E., Smith M.D. " My foot hurts": a flare of rheumatoid arthritis? Med J Aust 2009, 190:392-393.
30. Breebaart A.C., Bijlsma J.W., van Eden W. 16-Year remission of rheumatoid arthritis after unusually vigorous treatment of closed dental foci. Clin Exp Rheumatol 2002, 20:555-557.
31. Matsui T., Ohsumi K., Ozawa N., et al. CD64 on neutrophils is a sensitive and specific marker for detection of infection in patients with rheumatoid arthritis. J Rheumatol 2006, 33:2416-2424.
32. Nigrovic P.A., Lee D.M. Synovial mast cells: role in acute and chronic arthritis. Immunol Rev 2007, 217:19-37.
33. Karatay S., Erdem T., Yildirim K., et al. The effect of individualized diet challenges consisting of allergenic foods on TNF-alpha and IL-1beta levels in patients with rheumatoid arthritis. Rheumatology (Oxford) 2004, 43:1429-1433.
34. Panush R.S. Food induced (" allergic" ) arthritis: clinical and serologic studies. J Rheumatol 1990, 17:291-294.
35. Gaby A.R. Alternative treatments for rheumatoid arthritis. Altern Med Rev 1999, 4:392-402.
36. Darlington L.G. Dietary therapy for arthritis. Rheum Dis Clin North Am 1991, 17:273-285.
37. Darlington L.G., Ramsey N.W. Diets for rheumatoid arthritis. Lancet 1991, 338:1209-1210.
38. Karlson E.W., Mandl L.A., Aweh G.N., Grodstein F. Coffee consumption and risk of rheumatoid arthritis. Arthritis Rheum 2003, 48:3055-3060.
39. Mikuls T.R., Cerhan J.R., Criswell L.A., et al. Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2002, 46:83-91.
40. Hueber A.J., Asquith D.L., Miller A.M., et al. Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 2010, 184:3336-3340.
41. Pickens S.R., Volin M.V., Mandelin A.M., et al. IL-17 contributes to angiogenesis in rheumatoid arthritis. J Immunol 2010, 184:3233-3241.
42. Daoussis D., Andonopoulos A.P., Liossis S.N. Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. Semin Arthritis Rheum 2010, 39:369-383.
43. Stolt P., Kallberg H., Lundberg I., et al. Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005, 64:582-586.
44. Hart J.E., Laden F., Puett R.C., Costenbader K.H., Karlson E.W. Exposure to traffic pollution and increased risk of rheumatoid arthritis. Environ Health Perspect 2009, 117:1065-1069.
45. Criswell L.A., Saag K.G., Mikuls T.R., et al. Smoking interacts with genetic risk factors in the development of rheumatoid arthritis among older Caucasian women. Ann Rheum Dis 2006, 65:1163-1167.
46. Parks C.G., Walitt B.T., Pettinger M., et al. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the women's health initiative observational study. Arthritis Care Res (Hoboken) 2010, 63:184-194.
47. Lee D.H., Steffes M., Jacobs D.R. Positive associations of serum concentration of polychlorinated biphenyls or organochlorine pesticides with self-reported arthritis, especially rheumatoid type, in women. Environ Health Perspect 2007, 115:883-888.
48. Straub R.H., Pongratz G., Hirvonen H., et al. Acute cold stress in rheumatoid arthritis inadequately activates stress responses and induces an increase of interleukin 6. Ann Rheum Dis 2009, 68:572-578.
49. Sprent J., Cho J.H. Self/non-self discrimination and the problem of keeping T cells alive. Immunol Cell Biol 2008, 86:54-56.
50. Gaston M.S., Simpson A.H. Inhibition of fracture healing. J Bone Joint Surg Br 2007, 89:1553-1560.
51. Sloan A., Hussain I., Maqsood M., Eremin O., El-Sheemy M. The effects of smoking on fracture healing. Surgeon 2010, 8:111-116.
52. Pountos I., Georgouli T., Blokhuis T.J., Pape H.C., Giannoudis P.V. Pharmacological agents and impairment of fracture healing: what is the evidence? Injury 2008, 39:384-394.
53. Xian C.J., Zhou X.F. Treating skeletal pain: limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative. Nat Clin Pract Rheumatol 2009, 5:92-98.
54. Alblowi J., Kayal R.A., Siqueira M., et al. High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. Am J Pathol 2009, 175:1574-1585.
55. Munz C., Lunemann J.D., Getts M.T., Miller S.D. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 2009, 9:246-258.
56. van de Veerdonk F.L., Gresnigt M.S., Kullberg B.J., et al. Th17 responses and host defense against microorganisms: an overview. BMB Rep 2009, 42:776-787.
57. Awasthi A., Kuchroo V.K. Th17 cells: from precursors to players in inflammation and infection. Int Immunol 2009, 21:489-498.
58. Winthrop K.L., Chang E., Yamashita S., Iademarco M.F., LoBue P.A. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 2009, 15:1556-1561.
59. Bjarnason I., Williams P., So A., et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984, 2:1171-1174.
60. Picco P., Gattorno M., Marchese N., et al. Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters. Clin Exp Rheumatol 2000, 18:773-778.
61. Perrier C., Corthesy B. Gut permeability and food allergies. Clin Exp Allergy 2010, 41:20-28.
62. Xu D., Jiang H.R., Li Y., et al. IL-33 exacerbates autoantibody-induced arthritis. J Immunol 2010, 184:2620-2626.
63. Xu D., Jiang H.R., Kewin P., et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 2008, 105:10913-10918.
64. Kneilling M., Hultner L., Pichler B.J., et al. Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum 2007, 56:1806-1816.
65. Verri W.A., Souto F.O., Vieira S.M., et al. IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis 2010, 69:1697-1703.
66. Rohr P., Veit T.D., Scheibel I., et al. GSTT1, GSTM1 and GSTP1 polymorphisms and susceptibility to juvenile idiopathic arthritis. Clin Exp Rheumatol 2008, 26:151-155.
67. De Roos A.J., Cooper G.S., Alavanja M.C., Sandler D.P. Rheumatoid arthritis among women in the Agricultural Health Study: risk associated with farming activities and exposures. Ann Epidemiol 2005, 15:762-770.
68. Zeft A.S., Prahalad S., Lefevre S., et al. Juvenile idiopathic arthritis and exposure to fine particulate air pollution. Clin Exp Rheumatol 2009, 27:877-884.
69. Morgan A.W., Thomson W., Martin S.G., et al. Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population. Arthritis Rheum 2009, 60:2565-2576.
70. Bohanec Grabar P., Logar D., Tomsic M., Rozman B., Dolzan V. Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis. Clin Exp Rheumatol 2009, 27:229-236.
71. Plant D., Flynn E., Mbarek H., et al. Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann Rheum Dis 2010, 69:1548-1553.
72. Sugino H., Lee H.M., Nishimoto N. DNA microarray analysis of rheumatoid arthritis susceptibility genes identified by genome-wide association studies. Arthritis Res Ther 2010, 12:401.
73. Cerhan J.R., Saag K.G., Merlino L.A., Mikuls T.R., Criswell L.A. Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 2003, 157:345-354.
74. Hagfors L., Leanderson P., Skoldstam L., Andersson J., Johansson G. Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr J 2003, 2:5.
75. Zhang X., Rimpilainen M., Simelyte E., Toivanen P. Enzyme degradation and proinflammatory activity in arthritogenic and nonarthritogenic Eubacterium aerofaciens cell walls. Infect Immun 2001, 69:7277-7284.
76. Peltonen R., Nenonen M., Helve T., et al. Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet. Br J Rheumatol 1997, 36:64-68.
77. Mandel D.R., Eichas K., Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med 2010, 10:1.
78. Deschner J., Hofman C.R., Piesco N.P., Agarwal S. Signal transduction by mechanical strain in chondrocytes. Curr Opin Clin Nutr Metab Care 2003, 6:289-293.
79. Perera P.M., Wypasek E., Madhavan S., et al. Mechanical signals control SOX-9, VEGF, and c-Myc expression and cell proliferation during inflammation via integrin-linked kinase, B-Raf, and ERK1/2-dependent signaling in articular chondrocytes. Arthritis Res Ther 2010, 12:R106.
80. Feldman D.E., De Civita M., Dobkin P.L., et al. Effects of adherence to treatment on short-term outcomes in children with juvenile idiopathic arthritis. Arthritis Rheum 2007, 57:905-912.
81. Liu J., Agarwal S. Mechanical signals activate vascular endothelial growth factor receptor-2 to upregulate endothelial cell proliferation during inflammation. J Immunol 2010, 185:1215-1221.
82. Barrett J.H., Brennan P., Fiddler M., Silman A. Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum 2000, 43:1010-1015.
83. Imrich R., Vlcek M., Aldag J.C., et al. An endocrinologist's view on relative adrenocortical insufficiency in rheumatoid arthritis. Ann NY Acad Sci 2010, 1193:134-138.
84. Harbuz M.S., Richards L.J., Chover-Gonzalez A.J., Marti-Sistac O., Jessop D.S. Stress in autoimmune disease models. Ann NY Acad Sci 2006, 1069:51-61.
85. vel Szic K.S., Ndlovu M.N., Haegeman G., Vanden Berghe W. Nature or nurture: let food be your epigenetic medicine in chronic inflammatory disorders. Biochem Pharmacol 2010, 80:1816-1832.
86. Nakayama H., Yaguchi T., Yoshiya S., Nishizaki T. Resveratrol induces apoptosis MH7A human rheumatoid arthritis synovial cells in a sirtuin 1-dependent manner. Rheumatol Int 2010, doi:10.1007/s00296-010-1598-8.
87. Shakibaei M., Buhrmann C., Mobasheri A. Resveratrol-mediated SIRT-1 interactions with p300 modulate RANKL-activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells. J Biol Chem 2011, 286:11492-11505.
88. de Man Y.A., Dolhain R.J., van de Geijn F.E., Willemsen S.P., Hazes J.M. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum 2008, 59:1241-1248.
89. Contreras-Yanez I., Ponce De Leon S., Cabiedes J., Rull-Gabayet M., Pascual-Ramos V. Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs. Am J Med Sci 2010, 340:282-290.
90. Peeva E., Fishman A.D., Goddard G., Wadler S., Barland P. Rheumatoid arthritis exacerbation caused by exogenous interleukin-12. Arthritis Rheum 2000, 43:461-463.
91. Rozenbaum M., Boulman N., Slobodin G., Ayubkhanov E., Rosner I. Polyarthritis flare complicating rheumatoid arthritis infliximab therapy: a paradoxic adverse reaction. J Clin Rheumatol 2006, 12:269-271.
92. Henriksson K., Uvnas-Moberg K., Nord C.E., Johansson C., Gullberg R. Gastrin, gastric acid secretion, and gastric microflora in patients with rheumatoid arthritis. Ann Rheum Dis 1986, 45:475-483.
93. Soderlin M.K., Bergsten U., Svensson B. Patient-reported events preceding the onset of rheumatoid arthritis: possible clues to aetiology. Musculoskeletal Care 2011, 9:25-31. for the Barfot Study Group.
94. Matsui T., Kuga Y., Kaneko A., et al. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis 2007, 66:1221-1226.
95. Holman A.J., Ng E. Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis. Auton Neurosci 2008, 143:58-67.
96. Ebringer A., Rashid T. Rheumatoid arthritis is an autoimmune disease triggered by Proteus urinary tract infection. Clin Dev Immunol 2006, 13:41-48.
97. Rider L.G., Wu L., Mamyrova G., Targoff I.N., Miller F.W. Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2010, 49:2381-2390.
98. de Achaval S., Suarez-Almazor M.E. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. Int J Clin Rheumtol 2010, 5:313-326.